JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

NCT05174585 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: JAB-BX102 (anti-CD73 monoclonal antibody)
BIOLOGICAL: pembrolizumab (anti-PD-1 monoclonal antibody)

Sponsor

Jacobio Pharmaceuticals Co., Ltd.

Collaborators

[object Object]